| CXSB2000117 | 重组抗CD19m-CD3抗体注射液 | A-319 | Injection | Biological Products(1) | Supplementary Application | 2020-12-02 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | In Review | 2020-12-01 | view |
| CXSL1700089 | 重组抗CD19m-CD3抗体注射液 | A-319 | Injection | Biological Products(1) | New Drug Application | 2017-09-08 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2018-10-15 | view |
| CXSB1600018 | 重组人粒细胞集落刺激因子-Fc融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2017-02-08 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2017-05-26 | view |
| CXSB1600019 | 重组人粒细胞集落刺激因子-Fc融合蛋白注射液 | | Injection | Biological Products | Supplementary Application | 2017-02-06 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2017-05-26 | view |
| CXSL1300076 | 注射用重组人白介素22-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2014-01-26 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2015-11-19 | view |
| CXSL1300043 | 贝格司亭 | | Other | Biological Products(1) | New Drug Application | 2013-09-30 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2014-11-21 | view |
| CXSB1200020 | 注射用重组人粒细胞集落刺激因子-Fc融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2013-08-28 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2014-05-16 | view |
| CXSL1000049 | 注射用重组人粒细胞集落刺激因子-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2011-01-11 | 健能隆医药技术（上海）有限公司 | Nutrilite Can Long Medical Technology (Shanghai) Co Ltd | Certificate Issued | 2012-10-30 | view |
